Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000278055 encodes a non-coding RNA, specifically an antisense transcript emerging from the MEST gene locus; it is classified as "misc RNA" and has no evidence supporting a role as a direct therapeutic target or as a protein-coding gene[3][7]. There is no association with known drugs, mechanisms of action, or validated biomarker or safety information. It may have regulatory or unknown function consistent with other long non-coding or antisense RNAs, but currently, it is not recognized as a canonical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MEST intronic transcript 1, antisense RNA conserved region 2 (MESTIT1_2).